We have located links that may give you full text access.
Cancer Health Impact Program (CHIP): Identifying social and demographic associations of mHealth access and cancer screening behaviors among Brooklyn residents.
Cancer Epidemiology, Biomarkers & Prevention 2019 Februrary 8
BACKGROUND: Bedford-Stuyvesant (BS) and Bushwick (BW) communities of Brooklyn, New York are the predominantly African-American and Hispanic neighborhoods within the main catchment area Memorial Sloan Kettering. Cancer is a leading cause of death, with a higher prostate (PCa) and colorectal cancer (CRC) mortality than New York City. Opportunity to design cancer interventions which leverage accessibility and acceptability of mobile health (mHealth) tools exists.
METHODS: Cancer Health Impact Program (CHIP) was formed for this purpose. A tablet and Health Information National Trends (HINTS)- based survey collected and analyzed patterns of PCa and CRC screening and mHealth access.
RESULTS: Among 783 participants, 77% had a smartphone, 40% access to a mobile health application. 17% reported blood stool kit testing and 26% reported PSA screening. Multivariable logistic regression models demonstrated participants who owned smartphones without access to a health app were significantly more likely to report blood stool kit testing compared to participants without smartphones. Access to a health app was not significantly associated with PSA testing. Non-Hispanic Whites were 86% less likely to report CRC screening compared to non-Hispanic Black participants (OR = 0.15, 95% CI 0.02-0.49). Participants with prior history of cancer were 3x more likely to report CRC screening (OR = 3.18, 95% CI 1.55-6.63).
CONCLUSIONS: Significant differences were observed by race/ethnicity, cancer history, age, and smartphone use for CRC; for PCa, only age was significant.
IMPACT: Smartphones and mobile health apps may be prevalent among minority communities, other social and demographic characteristics are more likely to influence screening behaviors.
METHODS: Cancer Health Impact Program (CHIP) was formed for this purpose. A tablet and Health Information National Trends (HINTS)- based survey collected and analyzed patterns of PCa and CRC screening and mHealth access.
RESULTS: Among 783 participants, 77% had a smartphone, 40% access to a mobile health application. 17% reported blood stool kit testing and 26% reported PSA screening. Multivariable logistic regression models demonstrated participants who owned smartphones without access to a health app were significantly more likely to report blood stool kit testing compared to participants without smartphones. Access to a health app was not significantly associated with PSA testing. Non-Hispanic Whites were 86% less likely to report CRC screening compared to non-Hispanic Black participants (OR = 0.15, 95% CI 0.02-0.49). Participants with prior history of cancer were 3x more likely to report CRC screening (OR = 3.18, 95% CI 1.55-6.63).
CONCLUSIONS: Significant differences were observed by race/ethnicity, cancer history, age, and smartphone use for CRC; for PCa, only age was significant.
IMPACT: Smartphones and mobile health apps may be prevalent among minority communities, other social and demographic characteristics are more likely to influence screening behaviors.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app